Symposia, Presentations, Publications, and Grants

Research Symposia

In collaboration with the Substance Use Priority Research Area (SUPRA), the Cannabis Center held its first annual research symposium at the Substance Use Research Event (SURE) on April 24, 2023 at the UK Gatton Student Center.

The cannabis science track included: 1) a keynote speaker, 2) a breakout session with early-career investigators, 3) featured posters and 4) two travel awards for two trainees presenting posters.

Substance Use Research Event 2024

Click here to view event details for the April 2024 SURE symposium

UK Cannabis Science Seminar Series

The Cannabis Center sponsors a series of Zoom seminars featuring national and international experts on cannabis science. This series provides UK students, faculty and the general public the chance to hear cutting-edge cannabinoid science across a wide variety of specialties (medicine, pharmacology, public health, impaired driving science, agriculture, legal and social justice).

These presentations are free to attend and are open to the public.

 

Seminar Series Past Speakers

See a selection of past seminar speakers.

Next Event: February 26, 2024

Click here to download more information.

Presentations, Publications, and Grants

Current Cannabis Grants

  1. Cannabis Modulation of Outcomes Related to Opioid Use Disorder: Opioid Withdrawal, Abuse Potential and Safety; Principal Investigator: Shanna Babalonis, Ph.D.; 04/01/2022 – 03/31/2026; $2,860,600; NIHR01 DA054347 
  2. Evaluation of Marijuana and Opioid Drug Interactions: Assessment of the Safety Profile, Abuse-Related Pharmacodynamic Effects and Models of Drug Intake; Principal Investigator: Shanna Babalonis, Ph.D.08/01/2018 – 07/31/2024; $2,348,996; NIH R01 DA045700 
  3. NIH P30 Grant: IU Bloomington Center for Cannabis, Cannabinoids and Addiction (IUB C3A) (2023) - pending UK subaward; UK Site Principal Investigator: Shanna Babalonis, Ph.D.; 09/01/2023 -08/30/2024; projected total for UK project: $50,000.

Recent Cannabis Publications

  1. Britch SC, Walsh SL, Vickers-Smith R, Babalonis S, Slavova S (2023). Cannabis toxicity-related inpatient hospitalizations and emergency department visits in Kentucky, 2017 to 2019. Substance Use& Misuse. 58(1):66-76. doi: 10.1080/10826084.2022.2148478. PMID: 36453437; PMCID:PMC9890590.
  2. Johnson EJ, Kilgore MW, Babalonis S (2022). Label accuracy of unregulated cannabidiol (CBD) products: measured concentration vs. label claim. Journal of Cannabis Research. 4(1):28. doi: 10.1186/s42238-022-00140-1. PMID: 35658956; PMCID: PMC9169299.
  3. Johnson EJ, Kilgore MW, Babalonis S (2022). Cannabidiol (CBD) product contamination: Quantitative analysis of Δ9-tetrahydrocannabinol (Δ9-THC) concentrations found in commercially available CBD products. Drug and Alcohol Dependence. 237:109522. doi: 10.1016/j.drugalcdep.2022.109522. PMID: 35690015; PMCID:PMC9899037.
  4. Costales B, Babalonis S, Brown J, Goodin A (2023). Cannabis impairment on driving performance: Clinical considerations. Medical Cannabis and Cannabinoids, 2023 Jan 30;6(1):8-14. doi: 10.1159/000528714. PMID:36814685; PMCID: PMC9940647.
  5. Peters EN, MacNair L, Harrison A, Feldner MT, Eglit GML, Babalonis S, Turcotte C, Bonn-Miller MO (2023). A Two-Phase, Dose-Ranging, Placebo-Controlled Study of the Safety and Preliminary Test of Acute Effects ofOral Tetrahydrocannabivarin (THCV) in Healthy Participants. Cannabis and Cannabinoid Research, in press. 
  6. Lile JA, Turner BW, Cox DH, Bonn-Miller MO, Katz NR, Shellenberg TP, Stoops WW, Strickland JC (2023). Cannabis use disorder treatment preference: a pilot survey in current users of cannabis. Journal of Addiction Medicine, in press. PMID: 36731101.

Events and Presentations

Medical Education (CME Events) 

Kentucky Psychiatric Medical Association
Louisville, KY; CME Event, March 2023 
Invited Presentation: Medical Cannabis in Kentucky: Pharmacology, Legal Status, Product Overview 
Presenter: Shanna Babalonis, PhD 

HEALing Communities Presentation, KY OPEN
Lexington, KY; CME Event, July 2023 
Invited Presentation; Cannabis in Kentucky: Focus on Opioid Interactions and Clinical Impact 
Presenter: Shanna Babalonis, PhD
 

National Presentation/Medical Education (CME Event) 

Cannabis Clinical Outcomes Research Conference 
Medical Marijuana Consortium, University of Florida
Orlando, FL; CME Event; May 2023 
Invited Keynote Speaker: Opioid and Cannabinoid Interactions: Abuse Potential and Clinical Implications 
Presenter: Shanna Babalonis, PhD
 

National Conference Presentation 

Lile JA, Turner BW, Cox DH, Bonn-Miller MO, Katz NR, Shellenberg TP, Stoops WW, Strickland JC (2023). Cannabis use disorder treatment preference: a pilot survey in current users of cannabis. 
College on Problems of Drug Dependence, Denver, CO, June 2023. 

 

International Conference Presentations 

Babalonis S, Lofwall MR, Nuzzo PA, Fanucchi LC, Walsh SL. Intranasal Opioids and Inhaled Cannabis: Abuse Potential, Physiological Effects and safety Profile in Humans. Plenary talk; podium presentation; 
International Cannabinoid Research Society, Toronto Canada, June 2023. 

Johnson E, Kilgore M, Babalonis S. Quantitation of 17 Phytocannabinoids in Hemp-Derived Oils: LC-MS/MS Method Validation and Product Data. International Cannabinoid Research Society, Galway, Ireland. July 2022.